Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan · Delayed Price · Currency is JPY 69.00
-1.00 (-1.43%)
Aug 27, 2026, 1:12 PM JST
TYO:4596 Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,579 | 1,918 | 1,454 | 2,767 | 4,048 | 3,977 |
Cash & Short-Term Investments | 1,579 | 1,918 | 1,454 | 2,767 | 4,048 | 3,977 |
Cash Growth | 38.63% | 31.91% | -47.45% | -31.64% | 1.79% | 57.01% |
Accounts Receivable | - | - | 5 | 1 | 3 | - |
Other Receivables | - | - | - | - | 1 | - |
Receivables | - | - | 5 | 1 | 4 | - |
Inventory | 9 | 3 | 10 | 36 | 7 | - |
Prepaid Expenses | - | 15 | 27 | 39 | 99 | 187 |
Other Current Assets | 177 | 32 | 35 | 26 | 23 | 461 |
Total Current Assets | 1,765 | 1,968 | 1,531 | 2,869 | 4,181 | 4,625 |
Property, Plant & Equipment | - | - | - | 129 | 203 | 192 |
Long-Term Investments | 10 | 10 | 10 | 17 | 34 | 14 |
Other Long-Term Assets | 1 | 1 | - | 1 | 1 | 1 |
Total Assets | 1,776 | 1,979 | 1,541 | 3,016 | 4,419 | 4,832 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 81 | 22 | 28 | 34 | 42 | 75 |
Accrued Expenses | 12 | 13 | 53 | 72 | 76 | 70 |
Current Portion of Leases | 15 | 13 | 10 | 55 | 39 | 62 |
Current Income Taxes Payable | 62 | 105 | 52 | 110 | 194 | 323 |
Current Unearned Revenue | - | - | - | - | - | 11 |
Other Current Liabilities | 3 | 4 | 8 | 11 | 9 | 1 |
Total Current Liabilities | 173 | 157 | 151 | 282 | 360 | 542 |
Long-Term Leases | - | 8 | - | 87 | 109 | 137 |
Other Long-Term Liabilities | 1 | - | - | - | 1 | - |
Total Liabilities | 174 | 165 | 151 | 369 | 470 | 679 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 119 | 577 | 33 | 2,141 | 2,066 | 1,308 |
Additional Paid-In Capital | 25,857 | 28,418 | 27,867 | 27,638 | 27,526 | 26,755 |
Retained Earnings | -22,921 | -25,732 | -25,056 | -25,670 | -24,180 | -22,164 |
Comprehensive Income & Other | -1,453 | -1,449 | -1,454 | -1,462 | -1,463 | -1,746 |
Shareholders' Equity | 1,602 | 1,814 | 1,390 | 2,647 | 3,949 | 4,153 |
Total Liabilities & Equity | 1,776 | 1,979 | 1,541 | 3,016 | 4,419 | 4,832 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 15 | 21 | 10 | 142 | 148 | 199 |
Net Cash (Debt) | 1,564 | 1,897 | 1,444 | 2,625 | 3,900 | 3,778 |
Net Cash Growth | 40.52% | 31.37% | -44.99% | -32.69% | 3.23% | 70.56% |
Net Cash Per Share | 15.39 | 29.71 | 25.63 | 47.22 | 79.16 | 82.97 |
Filing Date Shares Outstanding | 153.14 | 115.4 | 57.83 | 56.27 | 54.96 | 45.86 |
Total Common Shares Outstanding | 153.14 | 115.4 | 56.77 | 56.06 | 54.62 | 45.86 |
Working Capital | 1,592 | 1,811 | 1,380 | 2,587 | 3,821 | 4,083 |
Book Value Per Share | 10.46 | 15.72 | 24.49 | 47.21 | 72.30 | 90.56 |
Tangible Book Value | 1,602 | 1,814 | 1,390 | 2,647 | 3,949 | 4,153 |
Tangible Book Value Per Share | 10.46 | 15.72 | 24.49 | 47.21 | 72.30 | 90.56 |
Order Backlog | - | - | - | 4.69 | 4.2 | - |